Trade subject to notification - Medicult

Orkla ASA has acquired a right of 2 700 000 shares in a right issue in Medicult.

This represents 11.74 % of the current share capital (before the right issue has been completed). After the right issue has been completed this will represent 9.64 % of the share capital.
Rune Helland, SVP Investor Relations, Tel: +47 2254 4411